News

A cell therapy for regenerating broken spinal cord using lab-grown neurons enters human trials for the first time.
A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...
A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...
Oral presentation of clinical data from FT819 Phase 1 study highlights safety and efficacy of fludarabine-free treatment ...
Scientists discovered the spleen can support insulin-producing cells from the pancreas. This may change diabetes care.
Laminin 521 (Cat. No. GMP-LA5H24) successfully maintained rapid expansion of human iPSCs, enabling cell passaging after just ...
The latest imaging method from the Broad Institute uncovers structural disruptions in the nucleus associated with progeria at super-resolution.
The Global Stem Cell Therapy Market is set to witness a healthy growth rate of 20% by 2029. A favorable investment ...
New data finds novel cell therapy successfully converts “cold” ovarian tumors into “hot,” demonstrating potential to unlock ...
Osteogenic differentiation is essential for bone development, metabolism, and repair; however, the underlying regulatory relationships among genes remain poorly understood. To elucidate the ...
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf ...